Circuit Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Circuit Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11237
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Circuit Therapeutics Inc (Circuit Therapeutics) is a biotechnology company that offers discovery and development of transformational therapies. The company holds expertise in optogenetics technology. Its optogenetics allows control of specific neurons and drives their activity. Circuit Therapeutics also specializes in the fields of medical device development, gene therapy, engineering and drug discovery. The company technology is under evaluation for various neuropsychiatric disorders such as epilepsy, Parkinson’s disease. It works in partnership with science industry, academic institutions and business and local communities. Circuit Therapeutics is headquartered in Menlo Park, California, the US.

Circuit Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Circuit Therapeutics Enters into Research Agreement with H. Lundbeck 10
Circuit Therapeutics Enters into Contract Agreement with DARPA 11
Boehringer Ingelheim Enters into Partnership with Circuit Therapeutics 12
Circuit Therapeutics Enters Into Research Agreement With Boehringer Ingelheim For Drug Discovery 13
Licensing Agreements 14
Benitec Biopharma Enters into Licensing Agreement with Circuit Therapeutics 14
Circuit Therapeutics Inc – Key Competitors 15
Circuit Therapeutics Inc – Key Employees 16
Circuit Therapeutics Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Other Significant Developments 18
Jun 28, 2018: Complex Brain Circuitry Revealed Using New Single-Cell Sequencing Technology 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Circuit Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Circuit Therapeutics Enters into Research Agreement with H. Lundbeck 10
Circuit Therapeutics Enters into Contract Agreement with DARPA 11
Boehringer Ingelheim Enters into Partnership with Circuit Therapeutics 12
Circuit Therapeutics Enters Into Research Agreement With Boehringer Ingelheim For Drug Discovery 13
Benitec Biopharma Enters into Licensing Agreement with Circuit Therapeutics 14
Circuit Therapeutics Inc, Key Competitors 15
Circuit Therapeutics Inc, Key Employees 16

List of Figures
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Circuit Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Circuit Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 3M India Limited (3MINDIA):企業の財務・戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Regeneron Pharmaceuticals Inc (REGN)-製薬・医療分野:企業M&A・提携分析
    Summary Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company provides products for treating eye diseases, high low-density lipoprotein (LDL) choleste …
  • Axpo Holding AG:企業の戦略的SWOT分析
    Axpo Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Applus Services, S.A.:企業のM&A・事業提携・投資動向
    Applus Services, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Applus Services, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Development Bank of Southern Africa-エネルギー分野:企業M&A・提携分析
    Summary Development Bank of Southern Africa (DBSA) offers various leading and infrastructure development financial services. Its service offering includes debt limited non-recourse lending, mezzanine finance, and promotion of inter-regional integration and co-operation. It offers implementation serv …
  • Indian Oil Corporation Limited:企業の戦略・SWOT・財務情報
    Indian Oil Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Indian Oil Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ya-Man Ltd:企業の戦略・SWOT・財務分析
    Ya-Man Ltd - Strategy, SWOT and Corporate Finance Report Summary Ya-Man Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • LKQ Corporation:企業のM&A・事業提携・投資動向
    LKQ Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LKQ Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Halo Pharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Halo Pharma Inc (Halo) is a contract development and manufacturing organization which offers scientific and development expertise services. It offers project management, formulation development and analytical development services. The organization holds specialization in the development of m …
  • Alfa Laval AB (ALFA):企業の財務・戦略的SWOT分析
    Alfa Laval AB (ALFA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Otsuka Pharmaceutical Co., Ltd.:企業のM&A・事業提携・投資動向
    Otsuka Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Otsuka Pharmaceutical Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Syneron Medical Ltd:企業の戦略的SWOT分析
    Syneron Medical Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Bracco SpA:企業の戦略的SWOT分析
    Bracco SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Daisy Group PLC:企業のM&A・事業提携・投資動向
    Daisy Group PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Daisy Group PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Ferro Corporation:企業の戦略・SWOT・財務分析
    Ferro Corporation - Strategy, SWOT and Corporate Finance Report Summary Ferro Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vattenfall AB-エネルギー分野:企業M&A・提携分析
    Summary Vattenfall AB (Vattenfall) is a state-owned energy company that generates, distributes and sells electricity and heat. It is one of the leading generators of electricity and heat in Europe. The company also conducts the sale of gas and energy trading. Vattenfall generates power through vario …
  • Fagron NV (FAGR):製薬・医療:M&Aディール及び事業提携情報
    Summary Fagron NV (Fagron), formerly Arseus NV is a pharmaceutical compounding solution provider. The company offers products such as raw materials, extracts and tinctures, flammable products, anesthesia, ointment bases, syrups, suspension media, triturations, phyto pharmaflore, medispend, capsicard …
  • Reliance Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Reliance Life Sciences Pvt Ltd (Reliance Life Sciences) a subsidiary of Reliance Industries Limited, is a biotechnology company which manufactures and develops medical products for healthcare industry. The company’s product portfolio includes plasma proteins, biosimilars, proteins, steroid, …
  • Great Eastern Energy Corp Ltd (GEEC):企業の財務・戦略的SWOT分析
    Summary Great Eastern Energy Corp Ltd (GEECL), a subsidiary of YKM Holdings Pvt Ltd, is an oil and gas exploration and production company. The company carries out extraction and sale of coal bed methane coalbed methane gas. It operates upstream, midstream and downstream projects in Raniganj south bl …
  • Verbund AG (VER)-エネルギー分野:企業M&A・提携分析
    Summary Verbund AG (Verbund) is an electricity utility that generates, transmits, trades, and distributes electricity. It generates from renewable energy sources such as hydropower, biomass, wind, and solar power. The company constructs, operates and maintains power plants; trades electricity and ga …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆